Pharma companies are facing tougher challenges than ever to get drugs reimbursed. Our client wanted to know the best way to structure their PBAC application, while exploring other options.
To uncover the customer insights that would help uncover the right reimbursement approach.
We used scenario-based market research surveys with clinicians for this project, to get a closer look at the impacts of different reimbursement approaches. With 'combination' treatments becoming more and more relevant, this work would help pharma companies and the PBAC better understand how clinicians might 'sequence' new and expensive products.
Our insights provided evidence that could be used as supporting documentation in a PBAC submission. So that's exactly what our client did.